Evidence map›Paper›PMID 34111480›Full record

ArticleAppetite2021

Gut hormones, adipokines, and pro- and anti-inflammatory cytokines/markers in loss of control eating: A scoping review.

Yang Yu, I Diana Fernandez, Ying Meng, Wenjuan Zhao, Susan W Groth

Open access · greenAbstract readScoping Review
In one paragraph

Article in Appetite, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Binge eating disorder.Nature reviews. Disease primers · 2022
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yang YuSchool of Nursing, University of Rochester, 601 Elmwood Avenue, Rochester, NY, 14642, USA. Electronic address: yang_yu@urmc.rochester.edu.
I Diana FernandezSchool of Public Health, University of Rochester, 265 Crittenden Blvd, Rochester, NY, 14642, USA. Electronic address: diana_fernandez@urmc.rochester.edu.
Ying MengSchool of Nursing, University of Rochester, 601 Elmwood Avenue, Rochester, NY, 14642, USA. Electronic address: ying_meng@urmc.rochester.edu.
Wenjuan ZhaoDepartment of Oncology, Shanghai Medical College, Fudan University, 138 Yixueyuan Rd, Xuhui District, Shanghai, 200032, China. Electronic address: 18111170003@fudan.edu.cn.
Susan W GrothSchool of Nursing, University of Rochester, 601 Elmwood Avenue, Rochester, NY, 14642, USA. Electronic address: susan_groth@urmc.rochester.edu.
University of Rochester · USShanghai Medical College of Fudan University · CN

Funding

Delineation of the biopsychosocial risks of obesogenic eating behaviorsK23NR019014 · NINR · UNIVERSITY OF ROCHESTER · PI MENG, YING · 2019 to 2021
$463k
NINR NIH HHS K23 NR019014
6 · The paper itself

Abstract

Loss of control (LOC) eating is the defining feature of binge-eating disorder, and it has particular relevance for bariatric patients. The biomarkers of LOC eating are unclear; however, gut hormones (i.e., ghrelin, cholecystokinin [CCK], peptide YY [PYY], glucagon-like peptide 1 [GLP-1], and pancreatic polypeptide [PP]), adipokines (i.e., leptin, adiponectin), and pro- and anti-inflammatory cytokines/markers (e.g., high-sensitivity C-reactive protein [hsCRP]) are candidates due to their involvement in the psychophysiological mechanisms of LOC eating. This review aimed to synthesize research that has investigated these biomarkers with LOC eating. Because LOC eating is commonly examined within the context of binge-eating disorder, is sometimes used interchangeably with subclinical binge-eating, and is the latent construct underlying disinhibition, uncontrolled eating, and food addiction, these eating behaviors were included in the search. Only studies among individuals with overweight or obesity were included. Among the identified 31 studies, 2 studies directly examined LOC eating and 4 studies were conducted among bariatric patients. Most studies were case-control in design (n = 16) and comprised female-dominant (n = 13) or female-only (n = 13) samples. Studies generally excluded fasting total ghrelin, fasting CCK, fasting PYY, and fasting PP as correlates of the examined eating behaviors. However, there was evidence that the examined eating behaviors were associated with lower levels of fasting acyl ghrelin (the active form of ghrelin) and adiponectin, higher levels of leptin and hsCRP, and altered responses of postprandial ghrelin, CCK, and PYY. The use of GLP-1 analog was able to decrease binge-eating. In conclusion, this review identified potential biomarkers of LOC eating. Future studies would benefit from a direct focus on LOC eating (especially in the bariatric population), using longitudinal designs, exploring potential mediators and moderators, and increased inclusion of the male population.

Indexed as

AdipokinesBinge-Eating DisorderCytokinesGastrointestinal HormonesAnti-Inflammatory AgentsBiomarkersFemaleHumansMaleAdipokinesAnti-Inflammatory AgentsBiomarkersCytokinesGastrointestinal HormonesAdipokinesBinge-eatingCytokinesGut hormonesInflammationLoss of control eating

Identifiers

PMID34111480
PMCPMC10683926
OpenAlexW3172665151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.